Rep. Julie Johnson Purchases Shares of CME Group Inc. (NASDAQ:CME)

Key Points

• Representative Julie Johnson of Texas purchased shares of CME Group Inc. for an amount between $1,001 and $15,000, reflecting a growing interest in the financial sector.
• CME Group recently reported quarterly earnings of $2.96 per share, beating analysts' expectations, with a net margin of 58.48% and a 10.4% year-over-year revenue increase.
• The company declared a quarterly dividend of $1.25 per share, set to be paid on September 25th, with an annualized yield of 1.8% and a payout ratio of 48.40%.

Representative Julie Johnson (D-Texas) recently bought shares of CME Group Inc. NASDAQ: CME. In a filing disclosed on August 14th, the Representative disclosed that they had bought between $1,001 and $15,000 in CME Group stock on July 22nd. The trade occurred in the Representative's "CHASE BROKERAGE ACCOUNT (3935)" account.

Representative Julie Johnson also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of Seagate Technology NASDAQ: STX on 7/29/2025.
• Sold $1,001 - $15,000 in shares of Microsoft NASDAQ: MSFT on 7/29/2025.
• Sold $1,001 - $15,000 in shares of Parker-Hannifin NYSE: PH on 7/25/2025.
• Purchased $1,001 - $15,000 in shares of Packaging Corporation of America NYSE: PKG on 7/25/2025.
• Purchased $1,001 - $15,000 in shares of Chevron NYSE: CVX on 7/25/2025.
• Sold $1,001 - $15,000 in shares of Exxon Mobil NYSE: XOM on 7/25/2025.
• Sold $1,001 - $15,000 in shares of UnitedHealth Group NYSE: UNH on 7/24/2025.
• Sold $1,001 - $15,000 in shares of Philip Morris International NYSE: PM on 7/22/2025.
• Sold $1,001 - $15,000 in shares of BlackRock NYSE: BLK on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of Packaging Corporation of America NYSE: PKG on 7/22/2025.

CME Group Stock Down 0.3%

CME stock opened at $273.92 on Friday. The firm has a 50 day simple moving average of $275.52 and a 200-day simple moving average of $267.37. CME Group Inc. has a twelve month low of $204.16 and a twelve month high of $290.79. The company has a market capitalization of $98.72 billion, a P/E ratio of 26.52, a PEG ratio of 4.86 and a beta of 0.44. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12.

CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share for the quarter, beating analysts' consensus estimates of $2.91 by $0.05. The business had revenue of $1.69 billion for the quarter, compared to analysts' expectations of $1.68 billion. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The company's revenue was up 10.4% on a year-over-year basis. During the same period in the previous year, the business earned $2.56 earnings per share. On average, equities research analysts predict that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th will be given a dividend of $1.25 per share. The ex-dividend date of this dividend is Tuesday, September 9th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.8%. CME Group's dividend payout ratio (DPR) is presently 48.40%.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the company. Wayfinding Financial LLC bought a new position in shares of CME Group during the 1st quarter valued at $25,000. Webster Bank N. A. grew its position in CME Group by 206.9% in the second quarter. Webster Bank N. A. now owns 89 shares of the financial services provider's stock worth $25,000 after acquiring an additional 60 shares in the last quarter. Cornerstone Planning Group LLC grew its position in CME Group by 122.2% in the first quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider's stock worth $26,000 after acquiring an additional 55 shares in the last quarter. Highline Wealth Partners LLC boosted its position in shares of CME Group by 84.3% during the second quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider's stock valued at $26,000 after buying an additional 43 shares during the period. Finally, Golden State Wealth Management LLC raised its stake in shares of CME Group by 612.5% during the first quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock valued at $30,000 after acquiring an additional 98 shares in the last quarter. Hedge funds and other institutional investors own 87.75% of the company's stock.

Insider Activity

In other CME Group news, Director Daniel G. Kaye sold 500 shares of the company's stock in a transaction dated Thursday, May 22nd. The shares were sold at an average price of $282.42, for a total value of $141,210.00. Following the completion of the transaction, the director owned 3,668 shares in the company, valued at approximately $1,035,916.56. This represents a 12.00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Phyllis M. Lockett sold 1,060 shares of the company's stock in a transaction dated Monday, May 19th. The stock was sold at an average price of $277.88, for a total transaction of $294,552.80. Following the transaction, the director owned 3,108 shares of the company's stock, valued at approximately $863,651.04. This trade represents a 25.43% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 2,450 shares of company stock valued at $676,663. Insiders own 0.30% of the company's stock.

Analysts Set New Price Targets

Several research firms have weighed in on CME. Oppenheimer lifted their target price on CME Group from $300.00 to $303.00 and gave the company an "outperform" rating in a research note on Thursday, July 24th. JPMorgan Chase & Co. reduced their target price on CME Group from $223.00 to $211.00 and set an "underweight" rating for the company in a research report on Thursday, April 24th. Barclays set a $298.00 price objective on CME Group and gave the stock an "equal weight" rating in a research note on Thursday, July 24th. Erste Group Bank lowered CME Group from a "strong-buy" rating to a "hold" rating in a research note on Saturday, May 24th. Finally, Piper Sandler raised their target price on CME Group from $283.00 to $296.00 and gave the stock an "overweight" rating in a report on Tuesday, July 15th. Four analysts have rated the stock with a sell rating, nine have assigned a hold rating and four have given a buy rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $261.93.

About Representative Johnson

Julie Johnson (Democratic Party) is a member of the U.S. House, representing Texas' 32nd Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027. Johnson (Democratic Party) ran for election to the U.S. House to represent Texas' 32nd Congressional District. She won in the general election on November 5, 2024. Julie Johnson earned a B.A. in history and government from the University of Texas at Austin in 1987 and a J.D. from the University of Houston Law Center in 1991. Johnson's career experience includes working as an attorney.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.